Can-Fite BioPharma Ltd. 20-F filing
Filed 2026-03-26 · Report date 2025-12-31 · 2025
Filing metadata
- Accession number
- 0001213900-26-034447
- Form type
- 20-F
- CIK
- 0001536196
- Primary document
- https://www.sec.gov/Archives/edgar/data/1536196/000121390026034447/ea0282586-20f_canfite.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Can-Fite BioPharma Ltd..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $405,000 | - | - |
| Operating Income | $-9.9M | - | - |
| Net Income | $-9.8M | - | - |
| Eps Basic | -5.97 | - | - |
| Eps Diluted | -5.97 | - | - |
| Cash And Equivalents | $5.5M | - | - |
| Total Assets | $9.5M | - | - |
| Shareholders Equity | $5.6M | - | - |
| Operating Cash Flow | $-8.9M | - | - |
| Capital Expenditures | $2,000 | - | - |